Article

$1.5 million gift launches GRF capital campaign

A gift of $1,550,000 has kicked off the Glaucoma Research Foundation's first year of a comprehensive new strategic plan.

San Francisco-A gift of $1,550,000 has kicked off the Glaucoma Research Foundation's (GRF) first year of a comprehensive new strategic plan, said Thomas M. Brunner, GRF president and chief executive officer. The gift from Melza and F.T. Barr supports the foundation's $12 million, 3-year capital campaign setting strategic imperatives through 2011.

"This is an extraordinary gift and sets an inspiring example that beating glaucoma must be everyone's top priority," Brunner said. "An epidemic of blindness from glaucoma may be coming if we don't act now to get ahead of this . . . disease. Following [this] wonderful lead, increased giving from all of us will enable GRF to fund the innovative research that gives genuine hope we will prevail."

F.T. Barr, a GRF board member from Houston, said, "I feel so strongly that GRF is on the right track, [that] I have increased my gift by 50% from our last capital campaign."

The foundation's first major gift program, the Catalyst Circle, was also born in that campaign, bringing in more than 100 donors at the $1,000 level and above.

Strategic imperatives in GRF's plan:

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.